Manual Matches Numan Product Stack

This shows Numan is not competing in a niche, it is competing in a repeatable telehealth playbook that other European operators can copy. Manual has built a very similar stack, online assessment, clinician review, recurring ED and weight loss treatments, and home based diagnostics, which means differentiation comes less from category choice and more from execution, supply access, retention, and brand strength across chronic care journeys.

• Manual looks close to Numan in product design, not just category exposure. Its UK site sells ED treatments, weight loss injections, and diagnostics led care, while its Brazil hiring and legal footprint show it is already operating beyond the UK. That makes it a direct multi market analog, not a small local copycat.
  2 sifted 3 manual 5 manual 6 manual
• The overlap matters because these products share the same acquisition engine. A customer can enter through an ED questionnaire or weight loss quiz, then stay for repeat prescriptions, clinician support, and follow up testing. Numan uses the same bundled model, with weight loss now the majority of revenue and diagnostics embedded in follow up care.
  1 sacra 7 sacra
• The wider field is fragmenting by care model. Yazen is more weight loss focused, Mojo is therapy first and aimed at psychological ED without prescriptions, and Boots combines online prescribing with a trusted retail pharmacy brand, click and collect, and home test kits. Those rivals attack different parts of the same patient wallet.
  1 sacra 4 sacra 8 mojo 9 boots 10 boots 11 boots

The market is heading toward a handful of scaled European digital clinics that bundle medication, coaching, diagnostics, and pharmacy fulfillment under one brand. As GLP-1 supply normalizes and more incumbents digitize, the winners will be the companies that turn one off treatment demand into long duration, multi product patient relationships across more countries.